Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 3823
  • 3824
  • 3825
  • …
  • ›
  • »

2026-02-27

Laurentian Bank of Canada Non-GAAP EPS of C$0.65, revenue of C$251.6M

2026-02-27

TXNM Energy Non-GAAP EPS of $2.33 misses by $0.27, revenue of $2.17B beats by $20M

2026-02-27

Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters′ Option to Purchase Additional Shares

2026-02-27

TXNM Energy Reports 2025 Results, Transaction and Regulatory Updates

2026-02-27

Endeavour Silver reports Q4 results

2026-02-27

Escalade GAAP EPS of $0.27 beats by $0.07, revenue of $62.56M beats by $5.01M

2026-02-27

inTest Non-GAAP EPS of $0.16 beats by $0.05, revenue of $32.8M beats by $1.57M

2026-02-27

Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer

2026-02-27

SMALL CAP MOVERS: Seraphim Space raises $100m to build real scale

2026-02-27

Docebo GAAP EPS of $0.91 beats by $0.61, revenue of $63.04M beats by $0.42M

2026-02-27

New World Development revenue sinks 50% as debt reduction drive slows

2026-02-27

Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma

  • «
  • ‹
  • …
  • 3823
  • 3824
  • 3825
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 23/Apr/2026 13:09:52
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies